ABBOTT LABORATORIES — Director's Dealing 2017

Dec 15, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-12-14

Reporting Person: Salvadori Daniel Gesua Sive (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-14	Common shares without par value	M	28319	$47.00	Acquired	102117	Direct
2017-12-14	Common shares without par value	S	9839	$54.9010	Disposed	92278	Direct
2017-12-14	Common shares without par value	S	1483	$54.9100	Disposed	90795	Direct
2017-12-14	Common shares without par value	S	200	$54.9110	Disposed	90595	Direct
2017-12-14	Common shares without par value	S	200	$54.9150	Disposed	90395	Direct
2017-12-14	Common shares without par value	S	1900	$54.9200	Disposed	88495	Direct
2017-12-14	Common shares without par value	S	100	$54.9214	Disposed	88395	Direct
2017-12-14	Common shares without par value	S	6897	$54.93	Disposed	81498	Direct
2017-12-14	Common shares without par value	S	7700	$54.935	Disposed	73798	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-14	Option (right to buy)	$47	M	28319	Disposed	2025-02-19	Common shares (28319)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.